Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Exagen Inc. - Common Stock (NQ:XGN)

7.270 +0.050 (+0.69%)
Streaming Delayed Price 8:00:01 PM GMT, Jul 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Exagen Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Exagen Inc. to Participate in the 2023 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
From Exagen Inc.
Via GlobeNewswire
Exagen to Announce Third Quarter 2023 Financial Results on November 13, 2023
From Exagen Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
Exagen's Earnings Outlook
 
Via Benzinga
Exagen: Q1 Earnings Insights
 
Via Benzinga
Recap: Exagen Q1 Earnings
 
Via Benzinga
BTIG Maintains Buy Rating for Exagen: Here's What You Need To Know
 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
Exagen Announces Acceptance of Multiple Abstracts at ACR 2023 Annual Meeting
From Exagen Inc.
Via GlobeNewswire
Exagen Earnings Perspective: Return On Capital Employed
 
Via Benzinga
Exagen Earnings Preview
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
From Exagen Inc.
Via GlobeNewswire
Exagen Inc. Reports Strong Second Quarter 2023 Results
From Exagen Inc.
Via GlobeNewswire
Exagen Inc. to Participate in the Canaccord Genuity 43rd Annual Growth Conference
From Exagen Inc.
Via GlobeNewswire
Exagen to Announce Second Quarter 2023 Financial Results on August 7, 2023
From Exagen Inc.
Via GlobeNewswire
Exagen Inc. Appoints Paul Kim to Board of Directors
From Exagen Inc.
Via GlobeNewswire
Exagen Inc. to Participate in the William Blair 43rd Annual Growth Stock Conference
From Exagen Inc.
Via GlobeNewswire
Exagen Inc. Reports First Quarter 2023 Results
Record Physician Demand for AVISE® CTD 
From Exagen Inc.
Via GlobeNewswire
Earnings Scheduled For May 15, 2023
Companies Reporting Before The Bell • Caledonia Mining (AMEX:CMCL) is expected to report earnings for its first quarter. • Sohu.com (NASDAQ:SOHU) is projected to report earnings for its first quarter. 
Via Benzinga
Exagen Announces Campaign for Lupus Awareness Month
From Exagen Inc.
Via GlobeNewswire
Exagen to Announce First Quarter 2023 Financial Results on May 15, 2023
From Exagen Inc.
Via GlobeNewswire
Nike, Tencent Music Entertainment And 3 Stocks To Watch Heading Into Tuesday
With US futures trading higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Exagen Inc. Reports Fourth Quarter and Full Year 2022 Results
Record AVISE® CTD Volume in 2022 
From Exagen Inc.
Via GlobeNewswire
Exagen to Announce Fourth Quarter and Full Year Financial Results on March 20, 2023
From Exagen Inc.
Via GlobeNewswire
Exagen Inc. to Participate in Upcoming March Conferences
From Exagen Inc.
Via GlobeNewswire
Coya Therapeutics' Expansion Of Exclusive Worldwide Licensing Agreement With ARscience Biotherapeutics Could Have Outsized Impact On Neurodegenerative And Autoimmune Diseases Treatments
Houston, Texas-based Coya Therapeutics Inc. (NASDAQ: COYA) has just taken a giant leap in making effective proprietary treatments focused on certain neurodegenerative and autoimmune diseases available... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.